๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

14 recruiting trials

for Advanced Solid Tumors With MTAP Deletion

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) NCT07492680Phase 258 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Atlanta Bristol-Myers Squibb ยท Tests: BMS-986504, Daraxonrasib, Nivolumab + Relatlimab FDC, Temozolomide, Pumitamig A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413Phase 123 sites๐Ÿ“ Goodyear๐Ÿ“ Phoenix๐Ÿ“ Duarte IDEAYA Biosciences ยท Tests: IDE892, IDE397 A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors NCT07077434Phase 112 sites๐Ÿ“ Beijing๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou Bristol-Myers Squibb ยท Tests: BMS-986504 A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors NCT06973863Phase 14 sites๐Ÿ“ Wentworthville๐Ÿ“ Taichung๐Ÿ“ Taipei PharmaEngine ยท Tests: PEP08 A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors NCT07071090Phase 18 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Nanning Heronova Pharmaceuticals ยท Tests: DC50292A Study of GS-2426 in Participants With Advanced Solid Tumors NCT07601243Phase 16 sites๐Ÿ“ Boston๐Ÿ“ Grand Rapids๐Ÿ“ East Brunswick Gilead Sciences ยท Tests: GS-2426 Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors NCT06414460Phase 1, Phase 210 sites๐Ÿ“ Denver๐Ÿ“ New Haven๐Ÿ“ Indianapolis InSilico Medicine Hong Kong Limited ยท Tests: ISM3412 Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors NCT05732831Phase 1, Phase 226 sites๐Ÿ“ Palo Alto๐Ÿ“ Grand Junction๐Ÿ“ Lake Mary Tango Therapeutics, Inc. ยท Tests: TNG462, Pembrolizumab Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion NCT06968572Phase 13 sites๐Ÿ“ Guiyang๐Ÿ“ Nanjing๐Ÿ“ Shanghai Haisco Pharmaceutical Group Co., Ltd. ยท Tests: HSK41959 Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion NCT05245500Phase 125 sites๐Ÿ“ Phoenix๐Ÿ“ Lone Tree๐Ÿ“ Jacksonville Bristol-Myers Squibb ยท Tests: MRTX1719 A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors๏ผˆG-MAP 101๏ผ‰ NCT06796699Phase 125 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Suzhou Genhouse Bio Co., Ltd. ยท Tests: GH56 Capsule A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion NCT06672523Phase 13 sites๐Ÿ“ Budapest๐Ÿ“ Logroรฑo๐Ÿ“ Madrid Bristol-Myers Squibb ยท Tests: BMS-986504, [14C]-BMS-986504 A Phase I Study of SY-9453 in Patients With Advanced Solid Tumors NCT07469982Phase 11 site๐Ÿ“ Shanghai Shouyao Holdings (Beijing) Co. LTD ยท Tests: SY-9453 Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors NCT07128303Phase 112 sites๐Ÿ“ Boston๐Ÿ“ Boston๐Ÿ“ New Brunswick Gilead Sciences ยท Tests: GS-5319, Carboplatin, Pemetrexed, Pembrolizumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy